Abivax (ABVX) Other Non-Current Assets (2022 - 2025)
Abivax (ABVX) recorded quarterly Other Non-Current Assets of $727527.2 in Q4 2025, down 19.39% quarter-over-quarter from $902516.8 in Q1 2025, and down 28.18% on a YoY basis from $1.0 million in Q4 2024.
Abivax (ABVX) Other Non-Current Assets (2022 - 2025) Analysis & Trends
Abivax's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $727527.2 for Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 28.18% year-over-year to $727527.2; the TTM figure through Dec 2025 stood at $727527.2 (down 28.18% YoY), while the FY2025 annual figure was $727527.2, down 28.18% from the prior year.
- Other Non-Current Assets was $727527.2 for Q4 2025 at Abivax, down from $902516.8 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $13.8 million in Q4 2023 to a low of $727527.2 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $3.1 million across 4 years, with a median of $1.0 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 1208.83% in 2023, then slumped 92.68% in 2024.
- A 4-year view of Other Non-Current Assets shows it stood at $1.1 million in 2022, then jumped by 1208.83% to $13.8 million in 2023, then slumped by 92.68% to $1.0 million in 2024, then decreased by 28.18% to $727527.2 in 2025.
- The last three Other Non-Current Assets figures came in at $727527.2 (Q4 2025), $902516.8 (Q1 2025), and $1.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 2.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 727,527.20 |
| Mar 31, 2025 | 902,516.85 |
| Dec 31, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Dec 31, 2023 | 13.85 Mn |
| Dec 31, 2022 | 1.06 Mn |